Organon Return on Tangible Equity 2019-2025 | OGN
Current and historical return on tangible equity values for Organon (OGN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Organon Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.70B | $-5.31B | -13.11% |
| 2025-03-31 | $0.75B | $-5.56B | -14.16% |
| 2024-12-31 | $0.86B | $-5.62B | -16.53% |
| 2024-09-30 | $1.30B | $-4.87B | -25.39% |
| 2024-06-30 | $1.00B | $-5.14B | -18.71% |
| 2024-03-31 | $1.05B | $-5.27B | -19.05% |
| 2023-12-31 | $1.02B | $-5.21B | -18.05% |
| 2023-09-30 | $0.59B | $-5.75B | -9.91% |
| 2023-06-30 | $0.75B | $-5.75B | -12.47% |
| 2023-03-31 | $0.75B | $-5.96B | -12.02% |
| 2022-12-31 | $0.92B | $-6.14B | -14.45% |
| 2022-09-30 | $1.01B | $-6.34B | -15.56% |
| 2022-06-30 | $1.11B | $-6.38B | -16.67% |
| 2022-03-31 | $1.30B | $-6.52B | -18.96% |
| 2021-12-31 | $1.35B | $-6.76B | -25.40% |
| 2021-09-30 | $1.52B | $-6.90B | -42.93% |
| 2021-06-30 | $1.74B | $-7.25B | -96.31% |
| 2021-03-31 | $1.86B | $-0.36B | 43670.59% |
| 2020-12-31 | $2.16B | $0.38B | 2273.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.451B | $6.403B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.200B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Revvity (RVTY) | United States | $10.928B | 19.25 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| CareDx (CDNA) | United States | $0.690B | 12.72 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.444B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| ModivCare (MODV) | United States | $0.015B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |